Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Agilent Technologies
(NY:
A
)
131.80
-0.26 (-0.19%)
Streaming Delayed Price
Updated: 9:54 AM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Agilent Technologies
< Previous
1
2
...
13
14
15
16
17
18
19
20
Next >
Agilent Technologies Earnings Preview
November 19, 2021
Agilent Technologies (NYSE:A) is set to give its latest quarterly earnings report on Monday, 2021-11-22. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Dr. Otis Brawley Named to Agilent Board of Directors
November 18, 2021
From
Agilent Technologies, Inc.
Via
Business Wire
Following Rough Year, Is Burning Rock Set To Turn The Corner?
November 18, 2021
Key Takeaways: Burning Rock expects fourth-quarter revenue to grow just 6% year-on-year due to latest Covid-related travel restrictions in China Cancer testing specialist’s...
Via
Benzinga
A Look Into Agilent's Debt
November 18, 2021
Over the past three months, shares of Agilent Technologies (NYSE:A) moved lower by 5.02%. Before having a look at the importance of debt, let us look at how much debt...
Via
Benzinga
A Look Into Agilent's Price Over Earnings
November 18, 2021
In the current session, Agilent Technologies Inc. (NYSE:A) is trading at $162.09, after a 0.34% gain. Over the past month, the stock increased by 3.28%, and in the past...
Via
Benzinga
Analyst Ratings For Asana
October 22, 2021
Over the past 3 months, 6 analysts have published their opinion on Asana (NYSE:A...
Via
Benzinga
Analyst Ratings For Autoliv
September 17, 2021
Over the past 3 months, 7 analysts have published their opinion on Autoliv (NYSE:A...
Via
Benzinga
Expert Ratings For Asana
August 31, 2021
Over the past 3 months, 9 analysts have published their opinion on Asana (NYSE:A...
Via
Benzinga
Agilent Increases Cash Dividend to 21 Cents Per Share
November 17, 2021
From
Agilent Technologies, Inc.
Via
Business Wire
3 New ProShares ETFs Built for the Trends of the Future
November 02, 2021
Here are three new ETFs focused on future industries to research further as you decide where to invest your hard-earned wealth.
Via
InvestorPlace
Agilent Names John Palma to Lead Global Medical Affairs Organization
November 02, 2021
From
Agilent Technologies, Inc.
Via
Business Wire
Agilent Announces New Ion Mobility LC/Q-TOF and Enhanced Solutions for Biotherapeutics at ASMS 2021
November 01, 2021
From
Agilent Technologies Inc.
Via
Business Wire
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
October 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Gilead, Merck to Study Trodelvy-Keytruda Combo For Breast Cancer Gilead, Inc...
Via
Benzinga
10 Biggest Price Target Changes For Friday
October 29, 2021
Oppenheimer boosted the price target on Apple Inc. (NASDAQ:A...
Via
Benzinga
Agilent Companion Diagnostic Expands CE-IVD Mark in Europe to Include Triple-Negative Breast Cancer (TNBC)
October 28, 2021
From
Agilent Technologies Inc.
Via
Business Wire
Agilent to Webcast Fourth-Quarter Fiscal Year 2021 Financial Results Presentation
October 28, 2021
From
Agilent Technologies Inc.
Via
Business Wire
Agilent Commits to Net-Zero Greenhouse Gas Emissions by 2050
October 27, 2021
From
Agilent Technologies, Inc.
Via
Business Wire
ECLUSIVE: Agilent Commits to Net-Zero Greenhouse Gas Emissions By 2050
October 27, 2021
Agilent Technologies Inc (NYSE: A) has committed to achieving net-zero greenhouse gas emissions no later than 2050. Agilent has also committed to interim greenhouse gas reduction...
Via
Benzinga
Topics
Emissions
Agilent PD-L1 IHC 28-8 pharmDx Receives CE-IVD Mark as a Companion Diagnostic Test in Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
October 21, 2021
From
Agilent Technologies Inc.
Via
Business Wire
Agilent Receives FDA Companion Diagnostic Approval for Ki-67 IHC MIB-1 pharmDx in High-Risk Early Breast Cancer
October 13, 2021
From
Agilent Technologies Inc.
Via
Business Wire
Where Ameren Stands With Analysts
September 30, 2021
Over the past 3 months, 6 analysts have published their opinion on Ameren (NYSE:A...
Via
Benzinga
Agilent Announces Thought Leader Award to Bernhard Lendl at the TU Wien (Vienna)
September 28, 2021
From
Agilent Technologies Inc.
Via
Business Wire
Dr. Mikael Dolsten Named to Agilent Board of Directors
September 23, 2021
From
Agilent Technologies, Inc.
Via
Business Wire
Agilent Announces Cash Dividend of 19.4 Cents per Share
September 22, 2021
From
Agilent Technologies, Inc.
Via
Business Wire
A Look Into Agilent's Price Over Earnings
September 17, 2021
In the current session, Agilent Technologies Inc. (NYSE:A) is trading at $176.22, after a 1.70% gain. Over the past month, the stock increased by 4.81%, and in the...
Via
Benzinga
What 6 Analyst Ratings Have To Say About Autoliv
September 10, 2021
Over the past 3 months, 6 analysts have published their opinion on Autoliv (NYSE:A...
Via
Benzinga
Agilent Announces Thought Leader Award to David R. Liu at the Broad Institute
September 07, 2021
From
Agilent Technologies Inc.
Via
Business Wire
Sphere 3D Shares Dive On Discounted Equity Offering To Fund Crypto Mining
September 03, 2021
Data management firm Sphere 3D Corp (NASDAQ:A...
Via
Benzinga
Agilent and Visiopharm Expand Collaboration with Worldwide Distribution Agreement
September 02, 2021
From
Agilent Technologies Inc.
Via
Business Wire
Agilent to Present at Wells Fargo Virtual Healthcare Conference
September 01, 2021
From
Agilent Technologies Inc.
Via
Business Wire
< Previous
1
2
...
13
14
15
16
17
18
19
20
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.